![Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations](https://www.frontiersin.org/files/Articles/484200/fimmu-10-02458-HTML/image_m/fimmu-10-02458-g001.jpg)
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
![B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram](https://www.researchgate.net/publication/313232213/figure/fig2/AS:457339691114499@1486049687549/B-cell-lineage-and-surface-marker-expression-A-diagram-of-a-simplified-development-and.png)
B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram
![Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model](https://www.frontiersin.org/files/MyHome%20Article%20Library/478945/478945_Thumb_400.jpg)
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
![Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab](https://www.mdpi.com/brainsci/brainsci-10-00758/article_deploy/html/images/brainsci-10-00758-g001.png)
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
![B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-022-00619-z/MediaObjects/41571_2022_619_Fig1_HTML.png)
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
![B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Far3908/MediaObjects/13075_2013_Article_3910_Fig1_HTML.jpg)